At first glance, it looks like we're getting somewhere. It is the era of #MeToo, of women speaking up about workplace harassment and discrimination, and of programs aimed at improving diversity in the life sciences industry. But despite progress, transparency and awareness, old challenges remain.
Two years after LifeSci Advisors' infamous model-staffed J.P. Morgan afterparty prompted widespread outrage, another industry-associated event objectified women—and triggered some anger. It was this year's Party At BIO Not Associated with BIO, or PABNAB. And at the 2018 J.P. Morgan conference, more men named Michael gave company presentations than female CEOs all together.
In spite of these and other obstacles, women continue to rise to the top of the life sciences field by starting their own companies, taking high-level positions, and otherwise making waves and shaping the industry. And they're paving the way for those who come after them.
“We have gone from one woman on the leadership team to three or five: getting closer to equal numbers,” said Samantha Budd Haeberlein, head of clinical discovery and development for Alzheimer’s disease at Biogen, one of our 2017 honorees. “The conversation is today louder, more open and acceptable; not just the last bullet on a HR agenda topic.”
Each year at Fierce, we spotlight these trailblazing women. From industry professionals and academics to venture capitalists and regulatory officials, women are making their mark all over life sciences.
We invite you to share your nominations using the form below. We’re looking for women in biotech, pharma and medtech who stand out as leaders, innovators and mentors in organizations big and small. Be sure to submit your nominations by Monday, Aug. 13 for consideration in this year’s list, which will be published at the end of October. To get an idea of what we’re looking for, find last year's list here and 2016’s here.